University of Colorado Cancer Center - Cancer Clinical Trials Office /ID# 255128 — Aurora, Colorado

University of Colorado Cancer Center - Cancer Clinical Trials Office /ID# 255128 is a clinical research site located in Aurora, Colorado, United States 80045-7158.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

University of Colorado Cancer Center - Cancer Clinical Trials Office /ID# 255128 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Colorado Cancer Center - Cancer Clinical Trials Office /ID# 255128?

University of Colorado Cancer Center - Cancer Clinical Trials Office /ID# 255128 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Colorado Cancer Center - Cancer Clinical Trials Office /ID# 255128 conducted?

University of Colorado Cancer Center - Cancer Clinical Trials Office /ID# 255128 has 1 clinical trials on record, with 1 currently active. Their work covers Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers.

Is University of Colorado Cancer Center - Cancer Clinical Trials Office /ID# 255128 accredited by Crixeo Health?

University of Colorado Cancer Center - Cancer Clinical Trials Office /ID# 255128 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Colorado Cancer Center - Cancer Clinical Trials Office /ID# 255128?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.